Literature DB >> 31091195

Plasma and dried blood spot lysosphingolipids for the diagnosis of different sphingolipidoses: a comparative study.

Giulia Polo1, Alessandro P Burlina2, Enzo Ranieri3, Francesca Colucci1, Laura Rubert1, Antonia Pascarella1, Giovanni Duro4, Albina Tummolo5, Andrea Padoan6, Mario Plebani6, Alberto B Burlina1.   

Abstract

Background Lysosphingolipids, the N-deacylated forms of sphingolipids, have been identified as potential biomarkers of several sphingolipidoses, such as Gaucher, Fabry, Krabbe and Niemann-Pick diseases and in GM1 and GM2 gangliosidoses. To date, different methods have been developed to measure various lysosphingolipids (LysoSLs) in plasma. Here, we present a novel liquid chromatography tandem mass spectrometry (LC-MS/MS) assay for a simultaneous quantification of LysoSLs (HexSph, LysoGb3, LysoGM1, LysoGM2, LysoSM and LysoSM509) in dried blood spot (DBS). This LC-MS/MS method was used to compare the levels of LysoSLs in DBS and plasma in both affected patients and healthy controls. Methods Lysosphingolipids were extracted from a 3.2 mm diameter DBS with a mixture of methanol:acetonitrile:water (80:15:5, v/v) containing internal stable isotope standards. Chromatographic separation was performed using a C18 column with a gradient of water and acetonitrile both with 0.1% formic acid in a total run time of 4 min. The compounds were detected in the positive ion mode electrospray ionization (ESI)-MS/MS by multiple reaction monitoring (MRM). Results The method was validated on DBS to demonstrate specificity, linearity, lowest limit of quantification, accuracy and precision. The reference ranges were determined in pediatric and adult populations. The elevated levels of LysoSLs were identified in Gaucher disease (HexSph), Fabry disease (LysoGb3), prosaposin deficiency (HexSph and LysoGb3) and Niemann-Pick disease types A/B and C (LysoSM and LysoSM509). The correlation in the levels between DBS and plasma was excellent for LysoGb3 and HexSph but poor for LysoSM and LysoSM509. Conclusions Despite the fact that plasma LysoSLs determination remains the gold standard, our LC-MS/MS method allows a rapid and reliable quantification of lysosphingolipids in DBS. The method is a useful tool for the diagnosis of different sphingolipidoses except for Niemann-Pick type C.

Entities:  

Keywords:  Fabry disease; Gaucher disease; Krabbe disease; Niemann-Pick type A/B disease; Niemann-Pick type C disease; biomarkers; dried blood spot (DBS); gangliosidosis GM1; gangliosidosis GM2

Mesh:

Substances:

Year:  2019        PMID: 31091195     DOI: 10.1515/cclm-2018-1301

Source DB:  PubMed          Journal:  Clin Chem Lab Med        ISSN: 1434-6621            Impact factor:   3.694


  20 in total

1.  Application of a glycinated bile acid biomarker for diagnosis and assessment of response to treatment in Niemann-pick disease type C1.

Authors:  Rohini Sidhu; Pamela Kell; Dennis J Dietzen; Nicole Y Farhat; An Ngoc Dang Do; Forbes D Porter; Elizabeth Berry-Kravis; Janine Reunert; Thorsten Marquardt; Roberto Giugliani; Charles M Lourenço; Raymond Y Wang; Nina Movsesyan; Ellen Plummer; Jean E Schaffer; Daniel S Ory; Xuntian Jiang
Journal:  Mol Genet Metab       Date:  2020-11-18       Impact factor: 4.797

2.  Advancing Diagnosis and Treatment of Niemann-Pick C disease through Biomarker Discovery.

Authors:  Xuntian Jiang; Daniel S Ory
Journal:  Explor Neuroprotective Ther       Date:  2021-12-30

3.  Hemochromatosis Mimicked Gaucher Disease: Role of Hyperferritinemia in Evaluation of a Clinical Case.

Authors:  Carmela Zizzo; Irene Ruggeri; Paolo Colomba; Christiano Argano; Daniele Francofonte; Marcomaria Zora; Emanuela Maria Marsana; Giovanni Duro; Salvatore Corrao
Journal:  Biology (Basel)       Date:  2022-06-15

Review 4.  Diagnosing neuronopathic Gaucher disease: New considerations and challenges in assigning Gaucher phenotypes.

Authors:  Emily C Daykin; Emory Ryan; Ellen Sidransky
Journal:  Mol Genet Metab       Date:  2021-01-09       Impact factor: 4.797

5.  Detecting lysosomal storage disorders by glycomic profiling using liquid chromatography mass spectrometry.

Authors:  Justin Mak; Tina M Cowan
Journal:  Mol Genet Metab       Date:  2021-08-21       Impact factor: 4.204

6.  Application of N-palmitoyl-O-phosphocholineserine for diagnosis and assessment of response to treatment in Niemann-Pick type C disease.

Authors:  Rohini Sidhu; Pamela Kell; Dennis J Dietzen; Nicole Y Farhat; An Ngoc Dang Do; Forbes D Porter; Elizabeth Berry-Kravis; Charles H Vite; Janine Reunert; Thorsten Marquardt; Roberto Giugliani; Charles M Lourenço; Olaf Bodamer; Raymond Y Wang; Ellen Plummer; Jean E Schaffer; Daniel S Ory; Xuntian Jiang
Journal:  Mol Genet Metab       Date:  2020-01-22       Impact factor: 4.204

Review 7.  Highlights on Genomics Applications for Lysosomal Storage Diseases.

Authors:  Valentina La Cognata; Maria Guarnaccia; Agata Polizzi; Martino Ruggieri; Sebastiano Cavallaro
Journal:  Cells       Date:  2020-08-14       Impact factor: 6.600

Review 8.  Use of Dried Blood Spot Specimens to Monitor Patients with Inherited Metabolic Disorders.

Authors:  Stuart J Moat; Roanna S George; Rachel S Carling
Journal:  Int J Neonatal Screen       Date:  2020-03-26

9.  Value of Glucosylsphingosine (Lyso-Gb1) as a Biomarker in Gaucher Disease: A Systematic Literature Review.

Authors:  Shoshana Revel-Vilk; Maria Fuller; Ari Zimran
Journal:  Int J Mol Sci       Date:  2020-09-28       Impact factor: 5.923

10.  Plasma lyso-sphingomyelin levels are positively associated with clinical severity in acid sphingomyelinase deficiency.

Authors:  Margo Sheck Breilyn; Wenyue Zhang; Chunli Yu; Melissa P Wasserstein
Journal:  Mol Genet Metab Rep       Date:  2021-07-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.